Arthur Y Kim

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 15 papers. Top paper: “Reinfection With Severe Acute Respiratory Syndrome Coronavirus 2: What Goes Around May Come Back Around”.

Reinfection With Severe Acute Respiratory Syndrome Coronavirus 2: What Goes Around May Come Back Around

Clinical Infectious Diseases(2020)10.1093/cid/ciaa1541

N/A

0DataRank · unranked

17 citations

Rajesh T. Gandhi, Arthur Y Kim

Multi-ancestry fine mapping of interferon lambda and the outcome of acute hepatitis C virus infection

Genes and Immunity(2020)10.1038/s41435-020-00115-3

N/A

0DataRank · unranked

7 citations

Priya Duggal, Chloe L. Thio, Ana Valencia, Thomas R. OʼBrien, Rachel Latanich +27 more

A Multiancestry Sex-Stratified Genome-Wide Association Study of Spontaneous Clearance of Hepatitis C Virus

The Journal of Infectious Diseases(2020)10.1093/infdis/jiaa677

N/A

0DataRank · unranked

6 citations

Ana Valencia, Chloe L. Thio, James J. Goedert, Alessandra Mangia, Valeria Piazzolla +24 more

Desperate Times Call for Temperate Measures: Practicing Infectious Diseases During a Novel Pandemic

The Journal of Infectious Diseases(2020)10.1093/infdis/jiaa209

N/A

0DataRank · unranked

6 citations

Rajesh T. Gandhi, Arthur Y Kim, Mark J. Siedner

Risks and benefits of oral HIV pre-exposure prophylaxis for people with chronic hepatitis B

The Lancet HIV(2022)10.1016/s2352-3018(22)00123-0

N/A

0DataRank · unranked

19 citations

Joseph Larmarange, Arthur Y Kim, Patrick Coffié, Menan Gérard Kouamé, Anders Boyd +3 more

Trans-ancestral fine-mapping of MHC reveals key amino acids associated with spontaneous clearance of hepatitis C in HLA-DQβ1

The American Journal of Human Genetics(2022)10.1016/j.ajhg.2022.01.001

N/A

0DataRank · unranked

15 citations

Candelaria Vergara, Chloe L. Thio, Nicolas Vince, Venceslas Douillard, Alba Grifoni +28 more

Bebtelovimab for High-Risk Outpatients With Early COVID-19 in a Large US Health System

Open Forum Infectious Diseases(2022)10.1093/ofid/ofac565

N/A

0DataRank · unranked

10 citations

Andy Kim, Mary-Ruth M Joyce, Jennifer Johnson, Arthur Y Kim, Lindsey R. Baden +2 more

Clearance of Hepatitis B e Antigen in Untreated Chronic Hepatitis B Virus Infection: A Systematic Review and Meta-analysis

The Journal of Infectious Diseases(2022)10.1093/infdis/jiac168

N/A

0DataRank · unranked

8 citations

Anne F. Liu, Arthur Y Kim, Patrick Coffié, Menan Gérard Kouamé, Kenneth A. Freedberg +3 more

Oral antiviral therapies for COVID-19 in patients with advanced chronic kidney disease or kidney failure

Nephrology Dialysis Transplantation(2023)10.1093/ndt/gfad058

N/A

0DataRank · unranked

6 citations

Destiny Harden, Daiana Moreno, James E. Dinulos, Paul Hanna, Qiyu Wang +3 more

Evaluation of Hepatitis C Treatment Outcomes Among Patients Enrolled in Outpatient Parenteral Antibiotic Therapy—Boston, Massachusetts, 2016–2021

Open Forum Infectious Diseases(2023)10.1093/ofid/ofad342

N/A

0DataRank · unranked

4 citations

Dina Ashour, Fatma M. Shebl, Laura Platt, John J. Chiosi, Sandra B. Nelson +4 more

Virological, serological and clinical outcomes in chronic hepatitis B virus infection: development and validation of the HEPA-B simulation model

BMJ Open(2024)10.1136/bmjopen-2023-073498

N/A

0DataRank · unranked

1 citations

Arthur Y Kim, Anders Boyd, Farzad Noubary, Menan Gérard Kouamé, Xavier Anglaret +5 more

Severe outcomes of COVID-19 among adults with increased risk conditions: A population-based observational study

PLoS ONE(2025)10.1371/journal.pone.0316529

N/A

0DataRank · unranked

5 citations

Andy Kim, Ellen C. Caniglia, Mary-Ruth M Joyce, David Rubins, Arthur Y Kim +4 more

2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: Pemivibart for Pre-exposure Prophylaxis, Vilobelimab for Critical Illness, and Abatacept or Infliximab for Severe or Critical Illness

Clinical Infectious Diseases(2025)10.1093/cid/ciaf424

N/A

0DataRank · unranked

4 citations

Yngve Falck–Ytter, Lindsey R. Baden, Roger Bedimo, Kelly Cawcutt, Vincent Chi‐Chung Cheng +24 more

2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: Vilobelimab

Clinical Infectious Diseases(2025)10.1093/cid/ciaf235

N/A

0DataRank · unranked

1 citations

Adarsh Bhimraj, Kelly Cawcutt, Kathleen Chiotos, Amy Dzierba, Arthur Y Kim +24 more

2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: Infliximab

Clinical Infectious Diseases(2025)10.1093/cid/ciaf355

N/A

0DataRank · unranked

1 citations

Adarsh Bhimraj, Kelly Cawcutt, Kathleen Chiotos, Amy Dzierba, Arthur Y Kim +24 more